Cite
Use of statins and adverse outcomes in patients with atrial fibrillation: An analysis from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) general registry pilot phase.
MLA
Proietti, Marco, et al. “Use of Statins and Adverse Outcomes in Patients with Atrial Fibrillation: An Analysis from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) General Registry Pilot Phase.” International Journal of Cardiology, vol. 248, Dec. 2017, pp. 166–72. EBSCOhost, https://doi.org/10.1016/j.ijcard.2017.08.055.
APA
Proietti, M., Laroche, C., Nyvad, O., Haberka, M., Vassilikos, V. P., Maggioni, A. P., Boriani, G., & Lip, G. Y. h. (2017). Use of statins and adverse outcomes in patients with atrial fibrillation: An analysis from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) general registry pilot phase. International Journal of Cardiology, 248, 166–172. https://doi.org/10.1016/j.ijcard.2017.08.055
Chicago
Proietti, Marco, Cécile Laroche, Ole Nyvad, Maciej Haberka, Vassilios P. Vassilikos, Aldo P. Maggioni, Giuseppe Boriani, and Gregory Y.h. Lip. 2017. “Use of Statins and Adverse Outcomes in Patients with Atrial Fibrillation: An Analysis from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) General Registry Pilot Phase.” International Journal of Cardiology 248 (December): 166–72. doi:10.1016/j.ijcard.2017.08.055.